Privia Health Group, Inc. (NASDAQ:PRVA – Get Rating) saw a large drop in short interest in April. As of April 15th, there was short interest totalling 1,680,000 shares, a drop of 34.9% from the March 31st total of 2,580,000 shares. Based on an average daily volume of 715,500 shares, the short-interest ratio is currently 2.3 days. Approximately 2.1% of the company’s stock are short sold.
Shares of PRVA stock opened at $21.99 on Friday. The stock has a 50 day moving average of $25.49 and a two-hundred day moving average of $24.73. The company has a current ratio of 2.35, a quick ratio of 2.35 and a debt-to-equity ratio of 0.07. Privia Health Group has a 12 month low of $18.93 and a 12 month high of $50.77.
Privia Health Group (NASDAQ:PRVA – Get Rating) last posted its earnings results on Tuesday, March 22nd. The company reported ($0.12) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.29) by $0.17. The business had revenue of $275.33 million during the quarter, compared to the consensus estimate of $226.06 million. Privia Health Group had a negative return on equity of 54.01% and a negative net margin of 19.48%. On average, equities analysts anticipate that Privia Health Group will post 0.11 earnings per share for the current fiscal year.
In other news, EVP Thomas Bartrum sold 10,000 shares of the stock in a transaction dated Tuesday, February 22nd. The stock was sold at an average price of $25.32, for a total transaction of $253,200.00. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, COO Parth Mehrotra sold 20,000 shares of the stock in a transaction dated Tuesday, February 22nd. The shares were sold at an average price of $25.30, for a total value of $506,000.00. The disclosure for this sale can be found here. Insiders have sold a total of 95,288 shares of company stock valued at $2,482,053 over the last ninety days.
Institutional investors have recently bought and sold shares of the stock. Rockefeller Capital Management L.P. bought a new position in shares of Privia Health Group during the 4th quarter worth approximately $25,000. First Horizon Advisors Inc. bought a new position in shares of Privia Health Group during the 4th quarter worth approximately $26,000. FourThought Financial LLC bought a new position in shares of Privia Health Group during the 3rd quarter worth approximately $32,000. Gleason Group Inc. bought a new position in shares of Privia Health Group during the 1st quarter worth approximately $57,000. Finally, Fifth Third Bancorp bought a new position in shares of Privia Health Group during the 4th quarter worth approximately $68,000. Institutional investors and hedge funds own 53.88% of the company’s stock.
About Privia Health Group (Get Rating)
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
- Get a free copy of the StockNews.com research report on Privia Health Group (PRVA)
- Why is Chevron Stock Falling After Strong Earnings?
- MarketBeat: Week in Review 4/25 – 4/29
- Apple’s Numbers Complete Trifecta
- Rogers Communication Stock Should Be Launching Higher
- Iridium Communications Stock is Ready to Return to Orbit
Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.